Latest Breaking News On - Sobi investor relations team - Page 1 : comparemela.com

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLissa pavlukMeredith kayaFadi fakhouriLydia abad franchCaroline baumalExchange commissionApellis pharmaceuticals incSobi investor relations teamEuropean renal associationExchange commission onNational institute of healthEuropean unionNorth americaMiddle eastForward looking statement

Swedish Orphan Biovitrum AB: Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress

Swedish Orphan Biovitrum AB: Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire sobiFadi fakhouriCaroline baumalSobi investor relations teamApellis pharmaceuticals incNational institute of healthEuropean renal associationEuropean unionApellis pharmaceuticalsLydia abad franchMedical affairsChief medical officerGenetics homeAccessed novemberNorth america

Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress

Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire sobiCaroline baumalFadi fakhouriNational institute of healthSobi investor relations teamApellis pharmaceuticals incEuropean unionEuropean renal associationApellis pharmaceuticalsLydia abad franchMedical affairsChief medical officerGenetics homeAccessed novemberNorth america

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesDrug administrationSobi investor relations teamNorth americaNorth americanSwedish orphan biovitrumFast trackMacrophage activation syndromeSobi mediaInfection with usePrescribing informationSobi north americaMiddle east

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSobi investor relations teamDrug administrationAmerican society of clinical oncologyNorth americaNorth americanSwedish orphan biovitrumAmerican societyClinical oncologyAnnual meetingSobi mediaImportant safetyPrescribing informationSobi north americaMiddle east